SMNR: Semnur Pharmaceuticals, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
2 institutions reported holding $73 of Semnur Pharmaceuticals, Inc. on Form 13F (0 the quarter before). 2 opened a new position and 0 sold out. Shares held by institutions: new.
| Largest holders | Shares | Value |
|---|---|---|
| GAMMA Investing LLC | 116 | $58 |
| RHUMBLINE ADVISERS | 30 | $15 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.